Drug
Licogliflozin clinical trials
Also written LIK066.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Name
Development codes
- LIK066
- 11
Studies by the year they started
11 studies that test it; most in 2017 (6)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 6 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses licogliflozin is read from its arms, and is right about nine times in ten.
Testing it · 11
- Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.TerminatedPhase 2Novartis PharmaceuticalsNCT04065841Written as Licogliflozin
- A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With ObesityCompletedPhase 2Novartis PharmaceuticalsNCT03320941Written as LIK066
- Effect of LIK066 on Reduction of Fatty Content in Livers of Obese PatientsCompletedPhase 2Novartis PharmaceuticalsNCT03205150Written as LIK066
- Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary SyndromeCompletedPhase 2Novartis PharmaceuticalsNCT03152591Written as LIK066
- Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.CompletedPhase 2Novartis PharmaceuticalsNCT03131479Written as LIK066
- Effect of LIK066 on Body Weight in Patients With Elevated Body Mass IndexCompletedPhase 2Novartis PharmaceuticalsNCT02470403Written as LIK066
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedPhase 1/2Novartis PharmaceuticalsNCT01407003Written as LIK066
- A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight AdultsCompletedPhase 2Novartis PharmaceuticalsNCT03100058Written as LIK066
- A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart FailureTerminatedPhase 2Novartis PharmaceuticalsNCT03152552Written as LIK066
- Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes MellitusCompletedPhase 1/2Novartis PharmaceuticalsNCT01915849Written as LIK066
- Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With DiabetesWithdrawnPhase 2Novartis PharmaceuticalsNCT01824264Written as LIK066
Given in every arm · 1 — licogliflozin is usual care beside what is tested
Codes
What other systems call licogliflozin · ClinicalTrials.gg INT001387
- MeSH (NLM) C000709456licogliflozinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 57J06X6EI0LICOGLIFLOZINConfirmed FDA, NLM
- NCI Thesaurus C150375LicogliflozinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000709456 | licogliflozin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 57J06X6EI0 | LICOGLIFLOZIN | Confirmed FDA, NLM |
| NCI Thesaurus | C150375 | Licogliflozin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.